[1]
A. Szczepańska-Szerej, M. Wojtan, and B. Szajnoga, “The international normalized ratio (INR) as seen in a population of patients with atrial fibrillation and cerebral infarction undergoing long-term treatment with vitamin K antagonists”, Curr. Issues Pharm. Med. Sci., vol. 28, no. 4, pp. 269–272, Dec. 2015, doi: 10.1515/cipms-2015-0087.